Legionella pneumophila Serotype 1 Pneumonia in Patient Receiving Adalimumab
We describe a case of severe pneumonia caused by Legionella pneumophila serotype 1 in a woman receiving the tumor necrosis factor–α antagonist to treat rheumatoid arthritis. As use of tumor necrosis factor–α inhibitors increase, clinicians should consider their possible association with legionellosi...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Centers for Disease Control and Prevention
2012-11-01
|
| Series: | Emerging Infectious Diseases |
| Subjects: | |
| Online Access: | https://wwwnc.cdc.gov/eid/article/18/11/11-1505_article |
| _version_ | 1818788316997222400 |
|---|---|
| author | Terry C. Wuerz Owen Mooney Yoav Keynan |
| author_facet | Terry C. Wuerz Owen Mooney Yoav Keynan |
| author_sort | Terry C. Wuerz |
| collection | DOAJ |
| description | We describe a case of severe pneumonia caused by Legionella pneumophila serotype 1 in a woman receiving the tumor necrosis factor–α antagonist to treat rheumatoid arthritis. As use of tumor necrosis factor–α inhibitors increase, clinicians should consider their possible association with legionellosis. |
| first_indexed | 2024-12-18T14:21:44Z |
| format | Article |
| id | doaj.art-86e4967f41204627898f10b2941ef376 |
| institution | Directory Open Access Journal |
| issn | 1080-6040 1080-6059 |
| language | English |
| last_indexed | 2024-12-18T14:21:44Z |
| publishDate | 2012-11-01 |
| publisher | Centers for Disease Control and Prevention |
| record_format | Article |
| series | Emerging Infectious Diseases |
| spelling | doaj.art-86e4967f41204627898f10b2941ef3762022-12-21T21:04:50ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592012-11-0118111872187410.3201/eid1811.111505Legionella pneumophila Serotype 1 Pneumonia in Patient Receiving AdalimumabTerry C. WuerzOwen MooneyYoav KeynanWe describe a case of severe pneumonia caused by Legionella pneumophila serotype 1 in a woman receiving the tumor necrosis factor–α antagonist to treat rheumatoid arthritis. As use of tumor necrosis factor–α inhibitors increase, clinicians should consider their possible association with legionellosis.https://wwwnc.cdc.gov/eid/article/18/11/11-1505_articleLegionellaLegionella pneumophilalung abscessadalimumabanti-inflammatory agentsserotype 1 |
| spellingShingle | Terry C. Wuerz Owen Mooney Yoav Keynan Legionella pneumophila Serotype 1 Pneumonia in Patient Receiving Adalimumab Emerging Infectious Diseases Legionella Legionella pneumophila lung abscess adalimumab anti-inflammatory agents serotype 1 |
| title | Legionella pneumophila Serotype 1 Pneumonia in Patient Receiving Adalimumab |
| title_full | Legionella pneumophila Serotype 1 Pneumonia in Patient Receiving Adalimumab |
| title_fullStr | Legionella pneumophila Serotype 1 Pneumonia in Patient Receiving Adalimumab |
| title_full_unstemmed | Legionella pneumophila Serotype 1 Pneumonia in Patient Receiving Adalimumab |
| title_short | Legionella pneumophila Serotype 1 Pneumonia in Patient Receiving Adalimumab |
| title_sort | legionella pneumophila serotype 1 pneumonia in patient receiving adalimumab |
| topic | Legionella Legionella pneumophila lung abscess adalimumab anti-inflammatory agents serotype 1 |
| url | https://wwwnc.cdc.gov/eid/article/18/11/11-1505_article |
| work_keys_str_mv | AT terrycwuerz legionellapneumophilaserotype1pneumoniainpatientreceivingadalimumab AT owenmooney legionellapneumophilaserotype1pneumoniainpatientreceivingadalimumab AT yoavkeynan legionellapneumophilaserotype1pneumoniainpatientreceivingadalimumab |